Levels of plasma sulfatides C18: 0 and C24: 1 correlate with disease status in relapsing-remitting multiple sclerosis

Journal of Neurochemistry

Volumn 127, Issue 5, 2013, Pages 600-604

  Moyano, Ana L ^a   Pituch, Katarzyna ^a   Li, Guanan ^b   Van Breemen, Richard ^b   Mansson, Jan E ^c   Givogri, Maria I ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

autoimmunity; biomarkers; demyelination; multiple sclerosis; plasma; sulfatides

Indexed keywords

BIOLOGICAL MARKER; SULFATIDE;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; LIPID ANALYSIS; LIPID BLOOD LEVEL; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; SEX DIFFERENCE; STRUCTURE ANALYSIS; TANDEM MASS SPECTROMETRY; ULTRA PERFORMANCE LIQUID CHROMATOGRAPHY;

AUTOIMMUNITY; BIOMARKERS; DEMYELINATION; MULTIPLE SCLEROSIS; PLASMA; SULFATIDES;

ADULT; AUTOIMMUNITY; BIOLOGICAL MARKERS; CHROMATOGRAPHY, LIQUID; FEMALE; HUMANS; MALE; MASS SPECTROMETRY; MIDDLE AGED; MOLECULAR WEIGHT; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; RISK FACTORS; SULFOGLYCOSPHINGOLIPIDS; YOUNG ADULT;

EID: 84887613216     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12341     Document Type: Article

References (21)

1. Bielekova B., and, Martin R., (2004) Development of biomarkers in multiple sclerosis. Brain 127, 1463-1478.
2. Blomqvist M., Rhost S., Teneberg S., Lofbom L., Osterbye T., Brigl M., Mansson J. E., and, Cardell S. L., (2009) Multiple tissue-specific isoforms of sulfatide activate CD1d-restricted type II NKT cells. Eur. J. Immunol. 39, 1726-1735.
3. Compston A., and, Coles A., (2008) Multiple sclerosis. Lancet 372, 1502-1517.
4. Folch J., Lees M., and, Sloane Stanley G. H., (1957) A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226, 497-509.
5. Haghighi S., Lekman A., Nilsson S., Blomqvist M., and, Andersen O., (2012) Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis. Acta Neurol. Scand. 125, 64-70.
6. Haghighi S., Lekman A., Nilsson S., Blomqvist M., and, Andersen O., (2013) Increased CSF sulfatide levels and serum glycosphingolipid antibody levels in healthy siblings of multiple sclerosis patients. J. Neurol. Sci. 326, 35-39.
7. Isaac G., Pernber Z., Gieselmann V., Hansson E., Bergquist J., and, Mansson J. E., (2006) Sulfatide with short fatty acid dominates in astrocytes and neurons. FEBS J. 273, 1782-1790.
8. Ishizuka I., (1997) Chemistry and functional distribution of sulfoglycolipids. Prog. Lipid Res. 36, 245-319.
9. Jahng A., Maricic I., Aguilera C., Cardell S., Halder R. C., and, Kumar V., (2004) Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide. J. Exp. Med. 199, 947-957.
10. Kanter J. L., Narayana S., Ho P. P., Catz I., Warren K. G., Sobel R. A., Steinman L., and, Robinson W. H., (2006) Lipid microarrays identify key mediators of autoimmune brain inflammation. Nat. Med. 12, 138-143.
11. Katsavos S., and, Anagnostouli M., (2013) Biomarkers in multiple sclerosis: an up-to-date overview. Mult. Scler. Int. 2013, 340508.
12. Marbois B. N., Faull K. F., Fluharty A. L., Raval-Fernandes S., and, Rome L. H., (2000) Analysis of sulfatide from rat cerebellum and multiple sclerosis white matter by negative ion electrospray mass spectrometry. Biochim. Biophys. Acta 1484, 59-70.
13. Nicholas H. J., and, Taylor J., (1994) Central nervous system demyelinating diseases and increased release of cholesterol into the urinary system of rats. Lipids 29, 611-617.
14. Polman C. H., Reingold S. C., Banwell B., et al,. (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann. Neurol. 69, 292-302.
15. Quintana F. J., Farez M. F., Viglietta V., et al,. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc. Natl Acad. Sci. USA 105, 18889-18894.
16. Quintana F. J., Yeste A., Weiner H. L., and, Covacu R., (2012) Lipids and lipid-reactive antibodies as biomarkers for multiple sclerosis. J. Neuroimmunol. 248, 53-57.
17. Shamshiev A., Donda A., Carena I., Mori L., Kappos L., and, De Libero G., (1999) Self glycolipids as T-cell autoantigens. Eur. J. Immunol. 29, 1667-1675.
18. Shore V. G., Smith M. E., Perret V., and, Laskaris M. A., (1987) Alterations in plasma lipoproteins and apolipoproteins in experimental allergic encephalomyelitis. J. Lipid Res. 28, 119-129.
19. Subramanian L., Blumenfeld H., Tohn R., et al,. (2012) NKT cells stimulated by long fatty acyl chain sulfatides significantly reduce the incidence of type 1 diabetes in nonobese diabetic mice [corrected]. PLoS ONE 7, e37771.
20. Takahashi T., and, Suzuki T., (2012) Role of sulfatide in normal and pathological cells and tissues. J. Lipid Res. 53, 1437-1450.
21. Voskuhl R. R., and, Gold S. M., (2012) Sex-related factors in multiple sclerosis susceptibility and progression. Nat. Rev. Neurol. 8, 255-263.